May 1, 2025 Southlake, TX, May 01, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence ("AI")-powered medical technology company focused on transforming ECGs/EKGs to…
Partho Sengupta MD, DM, FACC, FASE and the transformation of diagnostic cardiology using AI. See the video: https://youtu.be/t_eQ-MPQJtI
HeartSciences' CEO Andrew Simpson discusses heart disease and our AI-ECG solutions using both MyoVista hardware and MyoVista Insights cloud-based solutions See the video: https://youtu.be/OrR2RtK3qvA Millions of ECGs are performed every…
MyoVista integrates SCG with ECG to provide both mechanical and electrical insights into heart health. It helps in the early detection of heart dysfunction. In today’s fast-evolving healthcare landscape, monitoring heart…
March 13, 2025 Southlake, TX, March 13, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (“AI”)-powered medical technology company focused on transforming ECGs/EKGs to…
March 10, 2025 Southlake, TX, March 10, 2025 (GLOBE NEWSWIRE) -- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (“AI”)-powered medical technology company focused on transforming…
